Sign in

CIK 0001808805

  • Non-accelerated filer
  • Smaller reporting company

Nautilus Biotechnology, Inc.

Sign in to watch
Ticker
NAUT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Entity type
Operating
EIN
981541723
Phone
+1 206-333-2001
Business address
2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
Former names
ARYA Sciences Acquisition Corp III
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Gift Chief Scientist gave 210,000 shares (gift)
  5. 4 Open-market buy Director bought 200,000 shares at $5.36 ($1,072,000)
  6. 4 Open-market buy CEO, President, and Secretary bought 250,000 shares at an average $4.72 ($1,181,176)
  7. 4 Open-market buy Director bought 50,000 shares at an average $4.51 ($225,505)
  8. 4 Open-market buy CFO and Treasurer bought 15,000 shares at $4.58 ($68,633)
  9. 4 Open-market buy Director bought 100,000 shares at $5.30 ($529,890)
  10. 4 Open-market buy Director bought 36,970 shares at an average $7.71 ($285,041)
  11. 4 Open-market buy CFO and Treasurer bought 17,500 shares at $7.71 ($134,925)
  12. 4 Open-market buy General Counsel bought 5,000 shares at $7.56 ($37,807)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Former Director bought 5,507,063 shares at an average $10.00 ($55,070,983)
  15. 4 Conversion Director acquired 499,000 shares (conversion)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 6 of 8 · 141 filings